Cato Institute Policy Analysis No . 72 : Compassion vs Control : FDA Investigational-Drug Regulation

  • Published 2010

Abstract

Victims of AIDS and other incurable diseases are denied access to potentially valuable experimental drugs by the U.S. Food and Drug Administration. Under the present law, no new drug or medical device can be sold until it has been approved as safe and effective" by the FDA. New-drug approval is an expensive process that routinely takes years to complete… (More)

Topics

  • Presentations referencing similar topics